---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-022193"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2025-03-10T23:59:59+00:00"
generated_at: "2026-05-25T00:49:32.456058+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma enters ATM equity facility for up to $50M with Citizens JMP Securities

## Summary
- ATM agreement allows sale of common stock up to $50M aggregate, subject to baby shelf limit of $5,514,200.
- Shares sold at market prices on Nasdaq via Citizens JMP as agent; commission is 3% of gross proceeds.
- Prospectus supplement dated March 10, 2025 filed under Rule 424(b); Company not obligated to sell any shares.
- ATM may be terminated by Company with 5 business days' notice or by Manager at any time.

## SEC filing metadata
- accession: 0001104659-25-022193
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2025-03-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465925022193/0001104659-25-022193-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465925022193/tm258583d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-022193
- JSON: https://secwatch.observer/filing/0001104659-25-022193.json
- Plain text: https://secwatch.observer/filing/0001104659-25-022193.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.